Related Experiment Video
Updated: Jul 30, 2025

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
Published on: August 5, 2021
RPGR-Related Retinopathy: Clinical Features, Molecular Genetics, and Gene Replacement Therapy
Shaima Awadh Hashem1,2, Michalis Georgiou1,2,3, Robin R Ali1,2,4
1UCL Institute of Ophthalmology, University College London, London EC1V 9EL, United Kingdom.
Abstract:
Retinitis pigmentosa GTPase regulator (RPGR) gene variants are the predominant cause of X-linked retinitis pigmentosa (XLRP) and a common cause of cone-rod dystrophy (CORD). XLRP presents as early as the first decade of life, with impaired night vision and constriction of peripheral visual field and rapid progression, eventually leading to blindness. In this review, we present RPGR gene structure and function, molecular genetics, animal models, RPGR-associated phenotypes and highlight emerging potential treatments such as gene-replacement therapy.

